Glass Enamel & Ophtalmic Optics, Volume. 50, Issue 1, 22(2022)

The Analysis of Clinical Trial of Slowing the Progression of Myopia in Children with Low Red Laser

ZHOU Lei1, QIU Kaikai2,3, and TONG Liyang1
Author Affiliations
  • 1[in Chinese]
  • 2[in Chinese]
  • 3[in Chinese]
  • show less

    The purpose of this study was to quantify the effectiveness of low-lever red laser (LLRDL) in slowing the progression of myopia axial length elongation. Myopic children aged 8 to 12 years were enrolled in a year (with follow-ups at 3 month and 6 month), single-masked, randomized clinical trial. Subjects in each group were randomized to either a LLRDL (test) group or single vision spectacles (control) group. This study was to assess the changing values from 3 and 6 month follow-ups from the baseline, especially the axial length. After 3 months and 6 months, 82.5% and 72.7% of myopic eyes of the subjects enrolled had no axial elongation compared with baseline, while the control group had 100% axial elongation, and there were significant differences between red light treatment group and control group (p<0.000 1). LLRDL had significant efficacy in control axial elongation. But there were no significant difference between chamber depth, cornea power or choroidal thickness.

    Tools

    Get Citation

    Copy Citation Text

    ZHOU Lei, QIU Kaikai, TONG Liyang. The Analysis of Clinical Trial of Slowing the Progression of Myopia in Children with Low Red Laser[J]. Glass Enamel & Ophtalmic Optics, 2022, 50(1): 22

    Download Citation

    EndNote(RIS)BibTexPlain Text
    Save article for my favorites
    Paper Information

    Category:

    Received: Dec. 22, 2021

    Accepted: --

    Published Online: Jan. 10, 2023

    The Author Email:

    DOI:10.13588/j.cnki.g.e.2096-7608.2022.01.004

    Topics